Calabar bean

Physostigma venenosum

Physostigma venenosum, commonly known as the calabar bean, originates from traditional medicine practices in West Africa. Traditionally, it has not been documented to have specific uses; however, its alkaloid physostigmine is of interest for its potential therapeutic applications. Scientific evidence suggests that physostigmine may improve cognitive function and reduce α-synuclein expression, which could be beneficial in Parkinson's disease research. Additionally, early studies indicate possible analgesic activity from the plant's extracts, though more comprehensive clinical trials are needed to confirm these findings. The alkaloid physostigmine is known for its cholinesterase inhibitory effects, which have shown promise in dementia treatment; however, further research is required to establish its efficacy and safety in human subjects. No significant safety concerns or drug interactions have been recorded, but due caution should be exercised given the historical toxicity of the plant.

Auf einen Blick
Beste Evidenz
D
Warnhinweise

Nur zur Information. Traditionelle Anwendung bedeutet keine nachgewiesene Wirksamkeit. Evidenz und Sicherheit variieren — siehe die angegebenen Quellen.

Was die Wissenschaft sagt

  • Physostigmin aus Physostigma venenosum zeigt Potenzial zur Verbesserung der kognitiven Funktionen und zum Reduzieren von α-Synukleinkonzentration in PD-Neuronallinien. D PMID
  • Einige Extrakte von Physostigma venenosum zeigten potenzielle Analgetikumsaktivität in In-Vitro-Rezeptor-Bindung-Tests auf. D PMID
  • Die Pflanze Physostigma venenosum führte zur Entwicklung von Physostigmamin, einem Augenhypertonika. D PMID
  • Die Studie dokumentierte die frühe Toxikologie und Wirkungen von Physostigmin aus den Samen von Physostigma venenosum, einschließlich ihrer Nutzung in lokalen Ritualen und der darauf folgenden wissenschaftlichen Untersuchung. D PMID
  • Physostigmin, ein Alkaloid von Physostigma venenosum, zeigt Potenzial als Cholinesterasen-Inhibitor relevant für den Demenzbehandlungsbereich. D PMID

Frequently asked questions

What is Calabar bean?

Calabar bean (Physostigma venenosum) is a plant documented in FolkKB's traditional-medicine reference, drawn from sourced literature and cross-checked against the evidence.

What does the scientific evidence say about Calabar bean?

5 sourced findings are recorded for Calabar bean; the strongest carries evidence grade D. For example: Physostigmin aus Physostigma venenosum zeigt Potenzial zur Verbesserung der kognitiven Funktionen und zum Reduzieren von α-Synukleinkonzentration in PD-Neuronallinien.

How strong is the evidence for Calabar bean?

The strongest finding for Calabar bean carries evidence grade D — preliminary or traditional. Grades run A (strongest) to D (preliminary or traditional).

Is Calabar bean safe? What are the side effects?

No major safety issues are recorded for Calabar bean in our sources, but the data may be incomplete. Consult a qualified professional before use.

Does Calabar bean interact with medications?

No drug interactions are recorded for Calabar bean in our sources. This does not rule them out — check with a pharmacist.

What are the common names of Calabar bean?

Calabar bean is also known as: Физостигма ядовитая, Fève de Calabar.

Is Calabar bean a proven treatment?

No. FolkKB is informational only. Traditional use and early findings are not proof of efficacy or safety — consult a qualified professional and never self-treat.

Quellen

  1. T2 Ethnomedicinally selected plants as sources of potential analgesic compounds: indication of in vitro biological activity in receptor binding assays. literature abstract metadata
  2. T2 The early toxicology of physostigmine: a tale of beans, great men and egos. literature abstract metadata
  3. T2 The role of phytochemicals in the treatment and prevention of dementia. literature abstract metadata
  4. T2 Nature as a source of drugs for ophthalmology. literature abstract metadata
  5. T2 A Review on Phytochemical Constituents used as Current Treatment Strategies for Neurodegenerative Disease. literature abstract metadata